Scheduled Maintenance Notice
Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.
Select Publications
Conference Abstracts
, 2025, 'High-Dose MDMA Pills, Heroin-Adulterated Stimulants and Nitazene Detections the Most Common Concerns; Reporting on Drug Alerts Issued in Australia for 2024', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014
, 2025, 'Identifying Concerns and Collaborating for Rapid Response; Preliminary Findings From the Formative Evaluation of the Prompt Response Network', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014
, 2025, 'Learnings From the Implementation of a Consumer Advisory Group for a Nation-Wide Randomised Placebo-Controlled Clinical Trial Investigating a Pharmacotherapy for Methamphetamine Withdrawal', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014
, 2025, 'Managing Gamma-Hydroxybutyrate Withdrawal With Early Baclofen Loading: A Retrospective Case Series', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014
, 2025, 'People Seeking Treatment for Methamphetamine Use Are Getting Older and Treatment Services Need to Adapt', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014
, 2025, 'The Effect of Amphetamine-Type Stimulant Use at Start of Treatment on Substance Use and Treatment Retention During Treatment Among Clients Enrolled in an Opioid Agonist Program', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014
, 2024, 'OBJECTIVE AND SUBJECTIVE SLEEP DURING LISDEXAMFETAMINE TREATMENT OF ACUTE METHAMPHETAMINE WITHDRAWAL: NEW MEASUREMENT PARADIGM', in Drug and Alcohol Dependence, Elsevier, Vol. 260, pp. 110067, http://dx.doi.org/10.1016/j.drugalcdep.2023.110067
, 2023, 'Oral naltrexone-bupropion combination pharmacotherapy for methamphetamine use disorder: Pilot study protocol', in Drug and Alcohol Review, Wiley, Adelaide, Australia, Vol. 42, presented at The Australasian Professional Society on Alcohol and other Drugs Annual Scientific Conference, Adelaide, Australia, 12 November 2023 - 15 November 2023, http://dx.doi.org/10.1111/dar.13749
, 2023, 'Participant experiences in a pilot study for methamphetamine withdrawal treatment: Implications for retention', in Drug and Alcohol Review, Wiley, Adelaide, Australia, Vol. 42, presented at The Australasian Professional Society on Alcohol and other Drugs Annual Scientific Conference, Adelaide, Australia, 12 November 2023 - 15 November 2023, http://dx.doi.org/10.1111/dar.13749
, 2023, 'Psilocybin-assisted psychotherapy for methamphetamine use disorder: Recruitment to a novel safety and feasibility trial', in Drug and Alcohol Review, Wiley, Adelaide, Australia, Vol. 42, presented at The Australasian Professional Society on Alcohol and other Drugs Annual Scientific Conference, Adelaide, Australia, 12 November 2023 - 15 November 2023, http://dx.doi.org/10.1111/dar.13749
, 2022, '"Sometimes I have a duty of care not to call 000": Reported practices, attitudes and factors influencing consumer responses to GHB overdose', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S64 - S64, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700111&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'An Australian national Prompt Response Network for emerging drugs', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S73 - S73, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700127&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'An exploratory analysis of actigraphy and sleep diaries in a methamphetamine withdrawal clinical trial', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S23 - S24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'Outcomes for clients in opioid treatment programs who use amphetamine type substances: Results from a retrospective analysis of routinely-collected clinical data', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S96 - S97, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700167&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'Strengthening first-line support for Australians who use drugs, their friends and families: A training needs analysis for alcohol and other drug helplines for calls relating to methamphetamine and emerging drugs of concern', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S27 - S28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'The AusMAP study: A protocol for a randomised, controlled feasibility study of a managed alcohol program in Australia', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S44 - S45, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'PHARMACOLOGICAL TREATMENT FOR METHAMPHETAMINE WITHDRAWAL: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS', in AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, SAGE PUBLICATIONS LTD, Vol. 56, pp. 208 - 209
, 2022, 'A study protocol for the PsiMA trial: Psilocybin assisted psychotherapy for methamphetamine use disorder', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S82 - S82
, 2019, 'A rapid clinical research priority setting study for substance use disorder due to methamphetamine and emerging drugs of concern in Australia', in Drug and Alcohol Review, Wiley, Hobart, Australia, Vol. 38, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference, Hobart, Australia, 10 November 2019 - 13 November 2019, http://dx.doi.org/10.1111/dar.12991
, 2019, 'Are we detoxing the right people, in the right setting and in the right way? A rapid review of the literature on withdrawal management', in Drug and Alcohol Review, Wiley, Hobart, Australia, Vol. 38, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference, Hobart, Australia, 10 November 2019 - 13 November 2019, http://dx.doi.org/10.1111/dar.12991
, 2019, 'Characteristics and treatment outcomes of the drug treatment population in New South Wales: Focus on amphetamine type stimulants', in Drug and Alcohol Review, Wiley, Hobart, Australia, Vol. 38, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference, Hobart, Australia, 10 November 2019 - 13 November 2019, http://dx.doi.org/10.1111/dar.12991
, 2019, 'Optimising care for people who inject drugs: A retrospective medical record review of staphylococcus aureus bactaraemia treatment', in Drug and Alcohol Review, Wiley, Hobart, Australia, Vol. 38, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference, Hobart, Australia, 10 November 2019 - 13 November 2019, http://dx.doi.org/10.1111/dar.12991
, 2019, 'What's in an app? Incorporating an automated consent procedure to recruit those who use methamphetamine to a harm reduction and early intervention smartphone-based application clinical trial', in Drug and Alcohol Review, Wiley, Hobart, Australia, Vol. 38, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference, Hobart, Australia, 10 November 2019 - 13 November 2019, http://dx.doi.org/10.1111/dar.12991
, 2019, 'CHARACTERISTICS AND TREATMENT OUTCOMES OF THE DRUG TREATMENT POPULATION IN NEW SOUTH WALES: FOCUS ON AMPHETAMINE TYPE STIMULANTS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S27 - S28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100070&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'OPTIMISING CARE FOR PEOPLE WHO INJECT DRUGS: A RETROSPECTIVE MEDICAL RECORD REVIEW OF STAPHYLOCOCCUS AUREUS BACTERAEMIA TREATMENT', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S22 - S23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'Concomitant medication use in ART-experienced Australian adults: data from the PAART Study', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, NY, New York, Vol. 21, pp. A50 - A50, presented at 18th International Workshop on Co-Morbidities and Adverse Drug Reactions in HIV, NY, New York, 12 September 2016 - 13 September 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000389747500044&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Reports
, 2026, Acceptability and Support for a Community-led Drug Reporting System in Australia, http://dx.doi.org/10.26190/unsworks/32651
, 2026, Acceptability and Support for a Community-led Drug Reporting System in Australia
, 2026, Nitazene and benzodiazepine test strips: current evidence, utility, and limitations, http://dx.doi.org/10.26190/unsworks/32371
, 2026, Prompt Response Network, Drug Alert Report 2025, http://dx.doi.org/10.26190/unsworks/32353
, 2026, Prompt Response Network, Drug Alert Report Q4, 2025, UNSW, Sydney, http://dx.doi.org/10.26190/unsworks/32230
, 2025, Prompt Response Network, Drug Alert Report Q3, 2025, http://dx.doi.org/10.26190/unsworks/31734
, 2025, Prompt Response Network, Drug Alert Report Q2, 2025, http://dx.doi.org/10.26190/unsworks/31407
, 2025, Prompt Response Network, Drug Alert Report 2024, http://dx.doi.org/10.26190/unsworks/31298
, 2025, Prompt Response Network, Drug Alert Report Q1 2025, http://dx.doi.org/10.26190/unsworks/31225
, 2024, NCCRED Clinical Research Funding Program Report 2018 - 2023, http://dx.doi.org/10.26190/unsworks/30272
, 2019, Management of withdrawal from alcohol and other drugs, The Sax Institute, http://dx.doi.org/10.57022/mjjp9930, https://doi.org/10.57022/mjjp9930
, 2019, Management of withdrawal from alcohol and other drugs: an evidence check rapid review brokered by the Sax Institute for the NSW Ministry of Health, Sax Institute, http://dx.doi.org/10.57022/mjjp9930.
Theses / Dissertations
, 2018, Antiretroviral therapy and treatment cascade outcomes in a cohort of adults living with HIV in Australia
Media
, 2026, VAN (Video abstract by NCCRED) - Lisdexamfetamine for methamphetamine dependence: findings from a randomised controlled trial, http://dx.doi.org/10.26190/unsworks/32631
, 2026, VAN (Video abstract by NCCRED) - S-Check: A trial of a smartphone app on help-seeking and motivation to change methamphetamine use, http://dx.doi.org/10.26190/unsworks/32632
, 2025, More Australians are overdosing on GHB. But there are ways to reduce your risk, The Conversation, https://theconversation.com/more-australians-are-overdosing-on-ghb-but-there-are-ways-to-reduce-your-risk-253128
, 2024, VAN (Video abstract by NCCRED) - Exploring barriers to treatment-seeking with women who use methamphetamine, http://dx.doi.org/10.26190/unsworks/30437
, 2024, VAN (Video abstract by NCCRED) - Lisdexamphetamine for the treatment of methamphetamine withdrawal: Safety and feasibility - the OLAM study, http://dx.doi.org/10.26190/unsworks/30443
, 2023, VAN (Video abstract by NCCRED) - The health & social characteristics of people who use methamphetamine in New South Wales, http://dx.doi.org/10.26190/unsworks/30637
, 2023, VAN (Video abstract by NCCRED) - Strengthening first line telephone support for people who use Methamphetamine, http://dx.doi.org/10.26190/unsworks/30436
, 2022, VAN (Video Abstracts by NCCRED) - Pharmacotherapies for Methamphetamine Withdrawal, http://dx.doi.org/10.26190/unsworks/30423
, 2022, VAN (Video Abstracts by NCCRED) - The GHB Cultures, Practices and Experiences study, http://dx.doi.org/10.26190/unsworks/30424
Preprints
, “There’s a big tag on my head”: exploring barriers to treatment seeking with women who use methamphetamine in Sydney, Australia, http://dx.doi.org/10.1101/2022.08.01.22278295
, Effect of a Smartphone App (S-Check) on Actual and Intended Help-Seeking and Motivation to Change Methamphetamine Use Among Adult Consumers of Methamphetamine in Australia: Randomized Waitlist-Controlled Trial (Preprint), http://dx.doi.org/10.2196/preprints.55663